TLR2 and Parkinson disease: IL-1β activates the TLR2/MyD88/NF-κB pathway in Parkinson’s disease, leading to α-synuclein spreading in Parkinson’s disease (PD), multiple-system atrophy (MSA), and dementia with Lewy bodies [19].